The mission of the RT/EC is to eliminate health disparities in the Inland Empire and nationally through the research training and education of the next generation of health disparities researchers. To accomplish this mission we have initiated a comprehensive pipeline of health disparities research trainees at various levels in their academic development (from high school to junior faculty) that is unique and innovative in the Inland Empire in its scope and focus. A flow chart describing this pipeline (Figure 1.3) is presented above in section I- Narrative Overview of the Proposed NIMHD COE. LLU-CHDMM has the resources, the experience, and the vision to contribute to the development of future leaders in biomedical research and medicine who will be well-prepared and highly motivated to eliminate health disparities. The PI and his colleagues have an extensive track record in establishing research training and education programs targeted to students from underrepresented and health disparities populations. Renewed NIMHD funding will help us realize our vision to continue widening and strengthening the fragile pipeline of underrepresented students preparing to become biomedical researchers and doctors in service to their communities and their country. The impact of combining our individual and institutional commitment with NIH grant support will be: 1) desired measurable outcomes within the Inland Empire;2) a model for eliminating health disparities through research training and education;3) a comprehensive pipeline that will bring a diversity of fresh ideas to advance the biomedical sciences;and 4) expansion of health knowledge in the student's own communities, resulting in healthier lifestyle practices.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD006988-03
Application #
8609526
Study Section
Special Emphasis Panel (ZMD1-RN)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
3
Fiscal Year
2014
Total Cost
$204,334
Indirect Cost
$75,004
Name
Loma Linda University
Department
Type
DUNS #
009656273
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
McMullen, James R W; Selleck, Matthew; Wall, Nathan R et al. (2017) Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget 8:43481-43490
Badal, Simone A M; Asuncion Valenzuela, Malyn M; Zylstra, Dain et al. (2017) Glaucarubulone glucoside from Castela macrophylla suppresses MCF-7 breast cancer cell growth and attenuates benzo[a]pyrene-mediated CYP1A gene induction. J Appl Toxicol 37:873-883
Woods-Burnham, Leanne; Basu, Anamika; Cajigas-Du Ross, Christina K et al. (2017) The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. Prostate 77:1601-1608
Ríos-Colón, Leslimar; Cajigas-Du Ross, Christina K; Basu, Anamika et al. (2017) Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. Oncotarget 8:24915-24931
Li, Jitian; Dai, Liping; Lei, Ningjing et al. (2016) Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget 7:43546-43556
Francis, Olivia L; Milford, Terry-Ann M; Martinez, Shannalee R et al. (2016) A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis. Haematologica 101:417-26
Spencer-Hwang, Rhonda; Soret, Sam; Ghamsary, Mark et al. (2016) Gender Differences in Respiratory Health of School Children Exposed to Rail Yard-Generated Air Pollution: The ENRRICH Study. J Environ Health 78:8-16
Ochs, Robert L; Mahler, Michael; Basu, Anamika et al. (2016) The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med 16:273-93
Basu, Anamika; Cajigas-Du Ross, Christina K; Rios-Colon, Leslimar et al. (2016) LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer. PLoS One 11:e0146549
Turay, David; Khan, Salma; Diaz Osterman, Carlos J et al. (2016) Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients. Cancer Invest 34:1-11

Showing the most recent 10 out of 92 publications